Es gab 50 kürzliche Insider-Transaktionen für Akoya Biosciences, Inc. (AKYA), darunter 23 Käufe und 26 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $3.92M und die gesamten Insider-Verkäufe auf $581.63K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Bamford Pascal, Ek John Frederick, Ramachandran Niro Ph.d. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — AKYA
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-06-01 |
Bamford Pascal |
Chief Clinical Officer |
RSU-Steuereinbehalt |
670 |
$1.25 |
$837.50 |
205,738 |
| 2025-04-01 |
Ek John Frederick |
CFO |
RSU-Steuereinbehalt |
16,432 |
$1.35 |
$22.18K |
248,202 |
| 2025-03-23 |
Ramachandran Niro Ph.d |
Chief Business Officer |
RSU-Steuereinbehalt |
2,310 |
$1.70 |
$3.93K |
287,210 |
| 2025-03-23 |
Mckelligon Brian |
President and CEO |
RSU-Steuereinbehalt |
7,550 |
$1.70 |
$12.84K |
420,126 |
| 2025-03-01 |
Ek John Frederick |
CFO |
RSU-Steuereinbehalt |
3,594 |
$1.63 |
$5.86K |
264,634 |
| 2025-03-01 |
Ramachandran Niro Ph.d |
Chief Business Officer |
RSU-Steuereinbehalt |
3,594 |
$1.63 |
$5.86K |
289,520 |
| 2025-03-01 |
Mckelligon Brian |
President and CEO |
RSU-Steuereinbehalt |
8,257 |
$1.63 |
$13.46K |
427,676 |
| 2025-03-01 |
Kamocsay Jennifer |
Chief Legal Officer |
RSU-Steuereinbehalt |
3,594 |
$1.63 |
$5.86K |
179,272 |
| 2025-03-01 |
Bamford Pascal |
Chief Clinical Officer |
RSU-Steuereinbehalt |
2,567 |
$1.63 |
$4.18K |
206,408 |
| 2024-11-19 |
Ek John Frederick |
CFO |
RSU-Zuteilung |
87,500 |
- |
- |
268,228 |
| 2024-11-19 |
Ramachandran Niro Ph.d |
Chief Business Officer |
RSU-Zuteilung |
87,500 |
- |
- |
295,424 |
| 2024-11-19 |
Mckelligon Brian |
President and CEO |
RSU-Zuteilung |
218,750 |
- |
- |
443,483 |
| 2024-11-19 |
Kamocsay Jennifer |
Chief Legal Officer |
RSU-Zuteilung |
87,500 |
- |
- |
186,717 |
| 2024-11-19 |
Bamford Pascal |
Chief Clinical Officer |
RSU-Zuteilung |
87,500 |
- |
- |
210,258 |
| 2024-10-02 |
Mendel Scott |
Director |
RSU-Zuteilung |
44,959 |
$2.68 |
$120.49K |
44,959 |
| 2024-08-29 |
Bamford Pascal |
Chief Clinical Officer |
Veräußerung |
15,000 |
$5.96 |
$89.4K |
- |
| 2024-08-29 |
Bamford Pascal |
Chief Clinical Officer |
RSU-Zuteilung |
40,000 |
- |
- |
122,758 |
| 2024-06-11 |
Mckelligon Brian |
President and CEO |
Informierter Verkauf |
7,500 |
$2.08 |
$15.63K |
224,733 |
| 2024-06-06 |
Mckelligon Brian |
President and CEO |
Informierter Verkauf |
7,500 |
$2.01 |
$15.06K |
224,733 |
| 2024-06-04 |
Shepler Robert G |
Director |
RSU-Zuteilung |
50,000 |
$2.01 |
$100.5K |
50,000 |
| 2024-06-04 |
Lai Goldman Myla |
Director |
RSU-Zuteilung |
50,000 |
$2.01 |
$100.5K |
50,000 |
| 2024-06-04 |
Schnettler Thomas P |
Director |
RSU-Zuteilung |
50,000 |
$2.01 |
$100.5K |
50,000 |
| 2024-06-04 |
Raffin Thomas A. |
Director |
RSU-Zuteilung |
50,000 |
$2.01 |
$100.5K |
50,000 |
| 2024-06-04 |
Mendel Scott |
Director |
RSU-Zuteilung |
50,000 |
$2.01 |
$100.5K |
50,000 |
| 2024-06-04 |
Winkler Matthew |
Director |
RSU-Zuteilung |
50,000 |
$2.01 |
$100.5K |
50,000 |
| 2024-04-01 |
Ek John Frederick |
CFO |
RSU-Steuereinbehalt |
14,272 |
$4.56 |
$65.08K |
180,728 |
| 2024-03-23 |
Pla Frederic |
Chief Operating Officer |
RSU-Steuereinbehalt |
2,006 |
$4.79 |
$9.61K |
101,500 |
| 2024-03-23 |
Ramachandran Niro Ph.d |
Chief Business Officer |
RSU-Steuereinbehalt |
2,006 |
$4.79 |
$9.61K |
207,924 |
| 2024-03-23 |
Mckelligon Brian |
President and CEO |
RSU-Steuereinbehalt |
7,135 |
$4.79 |
$34.18K |
224,733 |
| 2024-03-20 |
Mckelligon Brian |
President and CEO |
Informierter Verkauf |
7,500 |
$4.97 |
$37.24K |
231,868 |
| 2024-03-13 |
Shepler Robert G |
Director |
Schenkung (gegeben) |
369,592 |
- |
- |
- |
| 2024-03-13 |
Mckelligon Brian |
President and CEO |
Informierter Verkauf |
7,500 |
$4.94 |
$37.04K |
224,368 |
| 2024-03-13 |
Mckelligon Brian |
President and CEO |
Informierter Verkauf |
7,500 |
$4.94 |
$37.04K |
231,868 |
| 2024-03-01 |
Pla Frederic |
Chief Operating Officer |
RSU-Steuereinbehalt |
2,049 |
$6.03 |
$12.36K |
103,506 |
| 2024-03-01 |
Ramachandran Niro Ph.d |
Chief Business Officer |
RSU-Steuereinbehalt |
2,305 |
$6.03 |
$13.9K |
209,930 |
| 2024-03-01 |
Mckelligon Brian |
President and CEO |
RSU-Steuereinbehalt |
2,049 |
$6.03 |
$12.36K |
103,506 |
| 2024-03-01 |
Kamocsay Jennifer |
General Counsel |
RSU-Steuereinbehalt |
3,283 |
$6.03 |
$19.8K |
99,217 |
| 2024-02-22 |
Pla Frederic |
Chief Operating Officer |
RSU-Zuteilung |
70,000 |
$5.35 |
$374.5K |
70,000 |
| 2024-02-22 |
Ek John Frederick |
CFO |
RSU-Zuteilung |
70,000 |
$5.35 |
$374.5K |
70,000 |
| 2024-02-22 |
Ramachandran Niro Ph.d |
Chief Business Officer |
RSU-Zuteilung |
70,000 |
$5.35 |
$374.5K |
70,000 |
| 2024-02-22 |
Mckelligon Brian |
President and CEO |
RSU-Zuteilung |
175,000 |
$5.35 |
$936.25K |
175,000 |
| 2024-02-22 |
Kamocsay Jennifer |
General Counsel |
RSU-Zuteilung |
70,000 |
$5.35 |
$374.5K |
70,000 |
| 2023-12-19 |
Mckelligon Brian |
President and CEO |
Informierter Verkauf |
7,500 |
$4.48 |
$33.57K |
152,563 |
| 2023-12-12 |
Mckelligon Brian |
President and CEO |
Informierter Verkauf |
7,500 |
$4.25 |
$31.87K |
152,563 |
| 2023-11-20 |
Mckelligon Brian |
President and CEO |
Informierter Verkauf |
7,500 |
$4.39 |
$32.9K |
152,563 |
| 2023-11-06 |
Pla Frederic |
Chief Operating Officer |
RSU-Zuteilung |
30,000 |
- |
- |
70,555 |
| 2023-11-06 |
Kamocsay Jennifer |
General Counsel |
RSU-Zuteilung |
30,000 |
- |
- |
67,500 |
| 2023-09-07 |
Pla Frederic |
Chief Operating Officer |
Informierter Kauf |
13,000 |
$4.60 |
$59.81K |
13,000 |
| 2023-06-12 |
Shepler Robert G |
Director |
Informierter Kauf |
120,000 |
$5.00 |
$600K |
369,592 |
| 2023-06-12 |
Lai Goldman Myla |
Director |
Informierter Kauf |
20,000 |
$5.00 |
$100K |
20,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
